MicrobiomeDX Competitors and Similar CompaniesClear all

MicrobiomeDX's competitors and similar companies include Telix Pharmaceuticals, Fluxion Biosciences, Ecrins Therapeutics and Imugene.

	MicrobiomeDX MicrobiomeDX is a company that develops cancer immunotherapies.	Telix Pharmaceuticals Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care.	Fluxion Biosciences Fluxion Biosciences is a company developing systems for live cell analysis.	Ecrins Therapeutics Ecrins Therapeutics is a biotechnology company that focuses on the discovery and development of anti-cancer compounds.	Imugene Imugene is a clinical-stage immuno-oncology company developing cancer treatments.
Founding Date	Founding Date 2017	Founding Date 2015	Founding Date 2005	Founding Date 2010	Founding Date 2013
Type	Type Private	Type Public	Type Private	Type Private	Type Public
Tags	Tags Healthcare biotech clinical research drug development oncology	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology	Tags Healthcare biotech clinical research drug development oncology	Tags Healthcare biotech clinical research drug development oncology
Locations	Locations Houston, US HQ	Locations North Melbourne, AU HQ Milton, AU Sydney, AU Herstal, BE Burnaby, CA Kyoto, JP Lancy, CH see more	Locations Alameda, US HQ	Locations La Tronche, FR HQ	Locations SYDNEY, AU HQ
Employees	Employees 1	Employees 415	Employees 7	Employees 1	Employees N/A
Valuation ($)	Valuation ($) N/A	Valuation ($) 4.6 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 247 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $803.8m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $356m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $449m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit $4.4m (FY, 2025)
Net income	Net income N/A	Net income ($7.1m) (FY, 2025)	Net income N/A	Net income N/A	Net income ($69m) (FY, 2025)
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 280k (over 6 years ago)	Latest funding round $ 599.1k (almost 11 years ago)	Latest funding round N/A
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 22.5m	Total funding raised $ 2.7m	Total funding raised N/A